We tend to call a GPCR antibody “validated,” as if the question were settled. The GeneTex team makes the case for a humbler word, characterized, and for handing the hardest reagents in receptor biology back to the researchers who use them.

Boston, MA and Irvine, CA — [March 18, 2026] — Dr. GPCR, a nonprofit organization serving the global G protein-coupled receptor (GPCR) research community through education, curated scientific content, and community engagement, today announced a strategic media partnership with GeneTex, a multinational antibody manufacturer with long-standing expertise in reagent development and validation. Anti-GPCR antibody specificity has been a persistent challenge in the field — one with